Adiponectin deficiency linked with an inflammatory state is present in obesity, severe chronic hepatitis C-related steatosis, non-alcoholic fatty liver diseases such as hepatic steatosis and non-alcoholic steatohepatitis, and cancer70–74. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.